Drugs.com
JUNE 16, 2024
SUNDAY, June 16, 2024 -- Exploring Europe, taking an African safari, going on a trip to the tropics: In many cases, vaccines are needed for travel, and that's doubly true for children. According to pediatrician Dr. Lauren Nguyen, researching what.
Drug Patent Watch
JUNE 16, 2024
This chart shows the patent expirations for tablet dosed drugs over the next decade. The term of drug patents varies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
JUNE 16, 2024
Annual Drug Patent Expirations for RECARBRIO Recarbrio is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
Drug Patent Watch
JUNE 16, 2024
Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
JUNE 16, 2024
Annual Drug Patent Expirations for PLUVICTO Pluvicto is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
Expert insights. Personalized for you.
147 
Let's personalize your content